Registration for a live webinar on 'Gamma-delta T cells for immunotherapy of cancer' is now open.See webinar details
Prof. Martin Boeree Radboud University Nijmegen Medical Centre TB Referral Hospital Dekkerswald, The Netherlands1 Talk
Martin Boeree is Associate Professor in lung diseases, especially tuberculosis and non-tuberculous mycobacteria. He studied Medicine in the University of Groningen in the Netherlands and specialized as a pulmonologist in the University Medical Centre in the same town. He then went to Blantyre, Malawi in Africa to join the College... read moreof Medicine at the University of Malawi as a Senior Lecturer. He headed the Department of Medicine from 1996-2000. There, he has built experience with the treatment and research of tuberculosis especially related to HIV. He served as advisor for the National TB Program. In 2000, he returned to the Netherlands where he joined the Department of Lung Diseases at the Radboud University Nijmegen Medical Centre. He was concurrently Director of the University Centre for Chronic Diseases and TB referral hospital Dekkerswald from 2005-2010. He was Chair for the Dutch Society of Tropical Medicine and the Federation of the European Societies of Tropical Medicine and International Health. He acts as one of the national consultants TB and NTM for KNCV Tuberculosis Foundation and the Dutch Thoracic Society. Martin Boeree has more than 130 publications focusing on drug treatment of tuberculosis and non-tuberculous mycobacterial infections. He is Chief Investigator of the HIGHRIF consortium within the PanACEA consortium focusing on the quest to find the “right” dose of rifampicine in its potential to shorten the duration of drug sensitive TB.